0001567619-19-010747.txt : 20190514
0001567619-19-010747.hdr.sgml : 20190514
20190514121726
ACCESSION NUMBER: 0001567619-19-010747
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190514
DATE AS OF CHANGE: 20190514
EFFECTIVENESS DATE: 20190514
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: EFFECTOR THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001577561
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455286092
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-339536
FILM NUMBER: 19821504
BUSINESS ADDRESS:
STREET 1: 11180 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-925-8215
MAIL ADDRESS:
STREET 1: 11180 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
D
1
primary_doc.xml
X0708
D
LIVE
0001577561
EFFECTOR THERAPEUTICS, INC.
11180 Roselle Street
SAN DIEGO
CA
CALIFORNIA
92121
(858) 925-8215
DELAWARE
None
None
Corporation
true
Stephen
T.
Worland, Ph.D.
c/o eFFECTOR Therapeutics, Inc.
11180 Roselle Street
San Diego
CA
CALIFORNIA
92121
Executive Officer
Director
Laurence
Lasky, Ph.D.
c/o eFFECTOR Therapeutics, Inc.
11180 Roselle Street
San Diego
CA
CALIFORNIA
92121
Director
Simeon
J.
George, M.D.
c/o eFFECTOR Therapeutics, Inc
11180 Roselle Street
San Diego
CA
CALIFORNIA
92121
Director
Kenneth
Haas, J.D.
c/o eFFECTOR Therapeutics, Inc.
11180 Roselle Street
San Diego
CA
CALIFORNIA
92121
Director
Jonathan
D.
Root, M.D.
c/o eFFECTOR Therapeutics, Inc.
11180 Roselle Street
San Diego
CA
CALIFORNIA
92121
Director
David
Maki, J.D.
c/o eFFECTOR Therapeutics, Inc.
11180 Roselle Street
San Diego
CA
CALIFORNIA
92121
Director
Alana
McNulty
c/o eFFECTOR Therapeutics, Inc.
11180 Roselle Street
San Diego
CA
CALIFORNIA
92121
Executive Officer
Stefan
Larson, Ph.D.
c/o eFFECTOR Therapeutics, Inc.
11180 Roselle Street
San Diego
CA
CALIFORNIA
92121
Director
John
W.
Smither
c/o eFFECTOR Therapeutics, Inc.
11180 Roselle Street
San Diego
CA
CALIFORNIA
92121
Director
Denis
Patrick, Ph.D.
c/o eFFECTOR Therapeutics, Inc.
11180 Roselle Street
San Diego
CA
CALIFORNIA
92121
Director
Biotechnology
Decline to Disclose
- 06b
false
2019-04-30
false
true
false
0
21800011
20422514
1377497
For Series C, Preferred Stock.
false
25
0
0
0
false
EFFECTOR THERAPEUTICS, INC.
/s/ Stephen T. Worland, Ph.D.
Stephen T. Worland, Ph.D.
President and Chief Executive Officer
2019-05-13